Development of the Pedestrian Anger Scale. A Pilot Study.


Journal

The Spanish journal of psychology
ISSN: 1988-2904
Titre abrégé: Span J Psychol
Pays: England
ID NLM: 101095192

Informations de publication

Date de publication:
21 Oct 2019
Historique:
entrez: 22 10 2019
pubmed: 22 10 2019
medline: 24 3 2020
Statut: epublish

Résumé

Anger has been closely related to risky behavior, and this last has been related to road accidents. The current research aimed to develop and validate a self-report questionnaire to measure anger in pedestrians (n = 550, 40.73% male) of a wide age rage (14-65 years, M = 27.91, SD = 13.21). The Parallel Analysis showed that the 15 items of the Pedestrian Anger Scale fitted satisfactorily in a four-factor solution: Anger because of obstructions or slowdowns caused by other pedestrians (α = .79), Anger because of hostility from drivers (α = .64), Anger because of bad conditions of the infrastructure (α = .62), and Anger because of dangerous situations caused by vehicles (α = .71). The global scale had also a good internal consistency (α = .83). Further analyses suggested convergent, divergent and incremental validity by correlating the global score of the questionnaire with both risk and anger measures. Middle-aged people (19-30 years) scored higher in anger as pedestrians than eldest (> 45 years), η2 = .02, but no significant effect were obtained by gender. Practical implications from both clinical and road safety viewpoints are discussed, and both future research proposals and limitations of the current study are also commented.

Identifiants

pubmed: 31630695
doi: 10.1017/sjp.2019.36
pii: S1138741619000362
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

E37

Auteurs

David Herrero-Fernández (D)

Universidad Europea del Atlántico (Spain).

Mireia Oliva-Macías (M)

Universidad Europea del Atlántico (Spain).

Pamela Parada-Fernández (P)

Universidad Europea del Atlántico (Spain).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH